Unknown

Dataset Information

0

Enhancement by Nano-Diamino-Tetrac of Antiproliferative Action of Gefitinib on Colorectal Cancer Cells: Mediation by EGFR Sialylation and PI3K Activation.


ABSTRACT: Drug resistance complicates the clinical use of gefitinib. Tetraiodothyroacetic acid (tetrac) and nano-diamino-tetrac (NDAT) have been shown in vitro and in xenografts to have antiproliferative/angiogenic properties and to potentiate antiproliferative activity of other anticancer agents. In the current study, we investigated the effects of NDAT on the anticancer activities of gefitinib in human colorectal cancer cells. ?-Galactoside ?-2,6-sialyltransferase 1 (ST6Gal1) catalyzes EGFR sialylation that is associated with gefitinib resistance in colorectal cancers, and this was also investigated. Gefitinib inhibited cell proliferation of HT-29 cells (K-ras wild-type), and NDAT significantly enhanced the antiproliferative action of gefitinib. Gefitinib inhibited cell proliferation of HCT116 cells (K-ras mutant) only in high concentration, and this was further enhanced by NDAT. NDAT enhancedd gefitinib-induced antiproliferation in gefitinib-resistant colorectal cancer cells by inhibiting ST6Gal1 activity and PI3K activation. Furthermore, NDAT enhanced gefitinib-induced anticancer activity additively in colorectal cancer HCT116 cell xenograft-bearing nude mice. Results suggest that NDAT may have an application with gefitinib as combination colorectal cancer therapy.

SUBMITTER: Chang TC 

PROVIDER: S-EPMC6223990 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Enhancement by Nano-Diamino-Tetrac of Antiproliferative Action of Gefitinib on Colorectal Cancer Cells: Mediation by EGFR Sialylation and PI3K Activation.

Chang Tung-Cheng TC   Chin Yu-Tang YT   Nana André Wendindondé AW   Wang Shwu-Huey SH   Liao Yu-Min YM   Chen Yi-Ru YR   Shih Ya-Jung YJ   Changou Chun A CA   Yang Yu-Chen Sh YS   Wang Kuan K   Whang-Peng Jacqueline J   Wang Liang-Shun LS   Stain Steven C SC   Shih Ai A   Lin Hung-Yun HY   Wu Chih-Hsiung CH   Davis Paul J PJ  

Hormones & cancer 20180905 6


Drug resistance complicates the clinical use of gefitinib. Tetraiodothyroacetic acid (tetrac) and nano-diamino-tetrac (NDAT) have been shown in vitro and in xenografts to have antiproliferative/angiogenic properties and to potentiate antiproliferative activity of other anticancer agents. In the current study, we investigated the effects of NDAT on the anticancer activities of gefitinib in human colorectal cancer cells. β-Galactoside α-2,6-sialyltransferase 1 (ST6Gal1) catalyzes EGFR sialylation  ...[more]

Similar Datasets

| S-EPMC5317264 | biostudies-literature
| S-EPMC6524305 | biostudies-literature
2021-07-01 | GSE117846 | GEO
| S-EPMC9410344 | biostudies-literature
| S-EPMC4040364 | biostudies-literature
| S-EPMC4460513 | biostudies-literature
| S-EPMC10312608 | biostudies-literature
2024-09-01 | GSE183782 | GEO
2019-12-31 | GSE123066 | GEO
| S-EPMC3714155 | biostudies-literature